Matches in SemOpenAlex for { <https://semopenalex.org/work/W2118567508> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2118567508 endingPage "A837" @default.
- W2118567508 startingPage "A837" @default.
- W2118567508 abstract "To evaluate the efficacy and safety of methylphenidate compared to other pharmacological alternatives or placebo in the treatment of ADHD. Health technology assessments (HTA), randomized clinical trials (RCT) or systematic reviews (SR) of RCT were systematically researched. Inclusion criteria were placebo or pharmacological intervention as comparators, and children or adolescents as population. Studies about different dosis or presentations of methylphenidate were also selected. One ECR, four SR and two HTA were selected comparing methylphenidate to placebo, atomoxetine, buspirone, dexamphetamine. Methylphenidate was superior to placebo in the index of hyperactivity detected by parents and teachers, behavior during the execution of tasks, productivity in classroom and in precision of the activities. Response rates to treatment and abandonment were better as compared to atomoxetine. Compared to buspirone, methylphenidate was shown to be more effective in reducing the symptoms of ADHD. Benefits of methylphenidate on dexamphetamine are inconclusive. Low dose methylphenidate was superior to high dose in behavior improvement on the execution of tasks. There was no difference between long and short acting presentations. Regarding security: anorexia, insomnia, migraines, stomach pain and dizziness were often associated with methylphenidate. Primary studies showed methodological limitations such as low quality, short follow up and low capacity of generalization. The evaluation of the results should be cautious. It is necessary to find a balance between benefits and risks before starting the administration of methylphenidate in children and adolescents, especially in long-term treatments." @default.
- W2118567508 created "2016-06-24" @default.
- W2118567508 creator A5002451338 @default.
- W2118567508 creator A5004814553 @default.
- W2118567508 creator A5029002653 @default.
- W2118567508 creator A5037398425 @default.
- W2118567508 creator A5041785254 @default.
- W2118567508 creator A5060142955 @default.
- W2118567508 creator A5062330636 @default.
- W2118567508 creator A5084502288 @default.
- W2118567508 creator A5091158167 @default.
- W2118567508 date "2015-11-01" @default.
- W2118567508 modified "2023-09-30" @default.
- W2118567508 title "Evidence of Efficacy and Safety of Methylphenidate in the Treatment of Children or Adolescents with Attention Deficit Disorder and Hyperactivity (Adhd)" @default.
- W2118567508 doi "https://doi.org/10.1016/j.jval.2015.09.353" @default.
- W2118567508 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26534471" @default.
- W2118567508 hasPublicationYear "2015" @default.
- W2118567508 type Work @default.
- W2118567508 sameAs 2118567508 @default.
- W2118567508 citedByCount "0" @default.
- W2118567508 crossrefType "journal-article" @default.
- W2118567508 hasAuthorship W2118567508A5002451338 @default.
- W2118567508 hasAuthorship W2118567508A5004814553 @default.
- W2118567508 hasAuthorship W2118567508A5029002653 @default.
- W2118567508 hasAuthorship W2118567508A5037398425 @default.
- W2118567508 hasAuthorship W2118567508A5041785254 @default.
- W2118567508 hasAuthorship W2118567508A5060142955 @default.
- W2118567508 hasAuthorship W2118567508A5062330636 @default.
- W2118567508 hasAuthorship W2118567508A5084502288 @default.
- W2118567508 hasAuthorship W2118567508A5091158167 @default.
- W2118567508 hasBestOaLocation W21185675081 @default.
- W2118567508 hasConcept C118552586 @default.
- W2118567508 hasConcept C126322002 @default.
- W2118567508 hasConcept C142724271 @default.
- W2118567508 hasConcept C15744967 @default.
- W2118567508 hasConcept C168563851 @default.
- W2118567508 hasConcept C204787440 @default.
- W2118567508 hasConcept C27081682 @default.
- W2118567508 hasConcept C2777112843 @default.
- W2118567508 hasConcept C2778781522 @default.
- W2118567508 hasConcept C2780783007 @default.
- W2118567508 hasConcept C2908647359 @default.
- W2118567508 hasConcept C70410870 @default.
- W2118567508 hasConcept C71924100 @default.
- W2118567508 hasConcept C99454951 @default.
- W2118567508 hasConceptScore W2118567508C118552586 @default.
- W2118567508 hasConceptScore W2118567508C126322002 @default.
- W2118567508 hasConceptScore W2118567508C142724271 @default.
- W2118567508 hasConceptScore W2118567508C15744967 @default.
- W2118567508 hasConceptScore W2118567508C168563851 @default.
- W2118567508 hasConceptScore W2118567508C204787440 @default.
- W2118567508 hasConceptScore W2118567508C27081682 @default.
- W2118567508 hasConceptScore W2118567508C2777112843 @default.
- W2118567508 hasConceptScore W2118567508C2778781522 @default.
- W2118567508 hasConceptScore W2118567508C2780783007 @default.
- W2118567508 hasConceptScore W2118567508C2908647359 @default.
- W2118567508 hasConceptScore W2118567508C70410870 @default.
- W2118567508 hasConceptScore W2118567508C71924100 @default.
- W2118567508 hasConceptScore W2118567508C99454951 @default.
- W2118567508 hasIssue "7" @default.
- W2118567508 hasLocation W21185675081 @default.
- W2118567508 hasOpenAccess W2118567508 @default.
- W2118567508 hasPrimaryLocation W21185675081 @default.
- W2118567508 hasRelatedWork W1975343712 @default.
- W2118567508 hasRelatedWork W2016483680 @default.
- W2118567508 hasRelatedWork W2043552268 @default.
- W2118567508 hasRelatedWork W2061657687 @default.
- W2118567508 hasRelatedWork W2118374778 @default.
- W2118567508 hasRelatedWork W2122518346 @default.
- W2118567508 hasRelatedWork W2164165726 @default.
- W2118567508 hasRelatedWork W2188744409 @default.
- W2118567508 hasRelatedWork W2888169867 @default.
- W2118567508 hasRelatedWork W3108405003 @default.
- W2118567508 hasVolume "18" @default.
- W2118567508 isParatext "false" @default.
- W2118567508 isRetracted "false" @default.
- W2118567508 magId "2118567508" @default.
- W2118567508 workType "article" @default.